IMAX CORP

IMAX

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 1,023,852Value: $37.8M

**SIGNAL NOTE: Driehaus Capital IMAX Position Initiation** This signal appears misaligned with typical biotech thesis—IMAX is a cinema technology company, not a therapeutics play, suggesting either a data error or a non-core diversification move by Driehaus's growth team. Without clarity on the investment rationale (potential streaming/entertainment pivot, tech revaluation, or portfolio rebalancing), this $37.8M position warrants follow-up to determine if it reflects conviction in IMAX's business recovery or represents tactical capital deployment outside the firm's biotech mandate.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: